Product: Ranitidine Tablets, USP 150 mg, a.) 65 count bottles (NDC 49035-404-61) b.) 130 count bottles (NDC 49035-404-13) c.) 220 count  bottles (NDC 49035-404-65)  (Walmart) OTC
Reason for recall: CGMP Deviations: Presence of NDMA impurity detected in product.
Recall initiated: 20191001
Status: Completed
Classification: Class II
Recall type: Voluntary: Firm initiated